Tag Archives: CTC

MIT researchers’ new platform detects and extracts rare circulating tumor cells from live mouse models using a combination of laser excitation and a microfluidic chip. Circulating tumor cells (CTCs) — an intermediate form of cancer cell between a primary and ...

New technology could eventually make it easier, less painful, and less expensive to track the progress of patients undergoing treatment for malignant...

The therapeutic landscape of lung cancer has expanded significantly over the past decade. Advancements in molecularly targeted therapies, strategies to discover and treat resistance mutations, and development of personalized cancer treatments in the context of tumor heterogeneity and dynamic tumor ...

Company’s intellectual property portfolio now features 20 issued patents protecting its proprietary liquid biopsy platform technology Biocept, Inc. a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer ...

From using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting RNA sequencing of cancer cell clusters from the blood of pancreatic cancer patients, ...

March 22, 2017 11 am to 12 pm EDT Webinar Description: Recent technological developments enable the use of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) as cancer biomarkers, and potentially represent a non-invasive substitute for the biopsy. In ...

Developing non-invasive diagnostic tools in the field of head and neck oncology has been a challenge. Analysis of circulating tumour derivatives in a patient’s blood has been explored in other solid cancers. This includes analysis of circulating tumour DNA, intact ...